following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).. october 2006  (25).

executive director of saen michael budkie made these reports public in a letter addressed to chancellor carol christ on wednesday.

recommended:.

it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..

over the years, i�ve talked to reporters who are solidly addicted to obfuscations. like any addict, they have an army of excuses to rationalize their behavior.